Skip to content

Easing Scan Anxiety in Pediatric Oncology Caregivers Through Meditation-based Programs

A Mindfulness Approach to Scanxiety

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07420101
Enrollment
160
Registered
2026-02-19
Start date
2026-02-01
Completion date
2027-02-01
Last updated
2026-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Caregiver Anxiety, Caregiver Anxiety Related to Cancer Imaging, Pediatric Oncology

Keywords

Scanxiety, caregiver anxiety, caregiver support, meditation, mindfulness

Brief summary

"Scanxiety" is a term coined to describe anxiety related to imaging during cancer treatment and has not been robustly studied in pediatric oncology caregivers. Mindfulness-based Stress Reduction (MBSR) is a meditation-based program that offers a non-pharmacologic approach to managing stress. The main purposes of this study are two-fold: 1). to determine if scanxiety exists in the caregivers of pediatric oncology patients and 2.) if scanxiety is found, does the implementation of a mindfulness program help to improve caregiver anxiety related to imaging.

Detailed description

"Scanxiety" is a term coined to describe anxiety related to imaging during cancer treatment. It is multifactorial and includes anxiety leading up to the scan as well as the waiting period after imaging and prior to results, as well as worry about possible changes in treatment. It has been documented in adult oncology literature and is associated with lower quality of life. Past adult studies show an inverse relationship with time since diagnosis and scanxiety, the further out from diagnosis, the lower level of scanxiety. Scanxiety is higher in those with lower education levels and higher baseline anxiety. Though scanxiety has been sparsely acknowledged in pediatric oncology literature, anxiety has been documented in parents of pediatric patients receiving MRI's for various diagnoses. Although caregivers of pediatric oncology patients experience high levels of distress, to date there are no studies that have measured the presence of scanxiety specifically in caregivers of pediatric oncology patients. Therefore, there are no intervention studies attempting to ameliorate anxiety related to imaging in the caregivers of pediatric oncology patients. Mindfulness-based Stress Reduction (MBSR) is a meditation-based program that offers a non-pharmacologic approach to managing stress. Its effects of reducing stress and other stress-related outcomes including anxiety is documented in various populations including police officers, prison inmates, university students, adolescents with cardiac diagnoses, and healthcare professionals. It has also been used to decrease stress in oncology patients and the partners of adult oncology patients. MBSR sessions can be provided in person but are also effective in an online training format. Although it has been well-studied in a variety of populations, the effectiveness of MBSR has yet to be evaluated in the caregivers of pediatric oncology patients. In particular, this study aims to fill the scientific gap in exploring if MSBR may reduce scanxiety in this population.

Interventions

OTHERMindful Module Caregiver Packet

If Scanxiety was identified, patient's caregiver will receive the Mindful Module Caregiver Packet. The intervention group will receive the daily module on Days 1-7; Day 7 being the day before scan. At the end of the module (Day 7), they will be directed to two surveys (STAI and Feasibility of the Program).

Sponsors

Kimberley Roche
Lead SponsorOTHER
Connecticut Children's Medical Center
CollaboratorOTHER
UConn Health
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Phase 1: To determine if scanxiety occurs in the caregivers of pediatric oncology patients relative to imaging studies at Connecticut Children's. Phase 2: To test whether a MBSR-influenced online intervention program decreases caregiver scanxiety.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Able to understand spoken English and be able to read written English * 18 years of age or older * Able to understand and willing to sign informed consent document * Have access to a smart phone or tablet device that is able to receive texts * Is a caregiver of any age oncology patient (including patients above 18 years of age) * Caregiver of a patient that is scheduled for a routine scan (CT's, MRI's, PET scans) within the upcoming 3 months * If assigned to the Phase 2 intervention group, willing and able to eat a raisin (a box of which will be mailed to home address)

Exclusion criteria

* Oncology patient is of adult age and caring for self * Medically-diagnosed cognitive delay in caregiver (by self-disclosure in eligibility questionnaire) * Upcoming scan is due to concern for relapse/disease recurrence and is urgent * Upcoming scan is part of initial oncology work-up * Any non-routine surveillance scan

Design outcomes

Primary

MeasureTime frameDescription
Likert-Style Anxiety ScaleCaregivers will complete this 2 weeks before the scan.Used to determine if the caregivers of pediatric oncology patients experience scanxiety. This one-item instrument scale ranges from 1 (not anxious at all) to 5 (extremely anxious). The goal of this instrument is to grossly establish if Scanxiety is present in caregivers. If caregivers answer between 2 (A little anxious)-5 (Extremely anxious) it demonstrates levels of anxiety.
State-Trait Anxiety Inventory (STAI)If anxiety is demonstrated in caregivers, they will move into Phase 2 of this study either in the Intervention Arm or the Control Arm. The State-Trait Anxiety Inventory (STAI) will be administered on Timepoint Day 1 and again on Timepoint Day 7.Used to determine if the caregivers of pediatric oncology patients experience scanxiety. This 40-item self-reported survey measures anxiety. These 40 questions are divided into two 20-quesiton sections (one for "state" anxiety, and one for "trait" anxiety). Higher scores demonstrate high levels of anxiety. the scores range from 20-80 \[very high anxiety (\> 65), high anxiety (56-65), moderate anxiety (46-55), low anxiety (36-45) and very low anxiety (\< or = 35).
Feasibility of the ProgramWill be administered to caregivers in the Intervention Arm Only on Day 7.This questionnaire measures the ease of completion of the mindfulness modules, the perceived appeal of the mindfulness program, participant interest, likelihood of recommending the program to others, and participation in other mindfulness-based activities (e.g., yoga or meditation) outside of the study in a YES or NO response format.
Acceptability of Intervention Measure (AIM)Will be administered to both Intervention and Control Arm on both Day 1 and Day 7.To evaluate the study's ability to generate interest in similar programs and its perceived applicability. This 4-question scale has values ranging from 1 (Completely disagree), 2 Disagree, 3 Neither agree nor disagree, 4 Agree, and 5 Completely agree).
Intervention Appropriateness Measure (IAM)Timeframe: Will be administered on both intervention and Control Arm on both Day 1 and Day 7.To evaluate the study's ability to generate interest in similar programs its, perceived applicability and the likelihood of recommendation to other oncology families. This 4-question scale has values ranging from 1 (Completely disagree), 2 Disagree, 3 Neither agree nor disagree, 4 Agree, and 5 Completely agree).
Feasibility of Intervention Measure (FIM)Will be administered on both intervention and Control Arm on both Day 1 and Day 7.To evaluate the study's ability to generate interest in its ease of completion. This 4-question scale has values ranging from 1 (Completely disagree), 2 Disagree, 3 Neither agree nor disagree, 4 Agree, and 5 Completely agree).

Countries

United States

Contacts

CONTACTKimberley Roche, MSN, PPCNP-BC, APRN
KRoche01@connecticutchildrens.org860-545-9671
CONTACTAdam Barselau, MS
Abarselau@connecticutchildrens.org860-545-9671
PRINCIPAL_INVESTIGATORKimberley Roche, MSN, PPCNP-BC, APRN

Connecticut Children's Medical Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 20, 2026